TWO SIGMA INVESTMENTS, LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$283,351
-24.3%
107,738
+1.6%
0.00%0.0%
Q2 2023$374,438
-41.8%
106,073
-49.0%
0.00%
-50.0%
Q1 2023$643,180
-46.5%
208,149
-26.7%
0.00%
-50.0%
Q4 2022$1,201,109
+506.6%
283,950
+239.6%
0.00%
+300.0%
Q3 2022$198,000
-54.9%
83,607
-45.8%
0.00%0.0%
Q2 2022$439,000
-8.4%
154,204
-7.4%
0.00%0.0%
Q1 2022$479,000
+327.7%
166,451
+945.5%
0.00%
Q3 2021$112,000
-78.0%
15,920
-71.3%
0.00%
-100.0%
Q2 2021$510,000
-82.8%
55,558
-76.1%
0.00%
-90.0%
Q2 2019$2,959,000
-40.2%
232,772
+82.3%
0.01%
-37.5%
Q1 2019$4,952,000
+95.6%
127,657
+2.6%
0.02%
+60.0%
Q4 2018$2,532,000
+1083.2%
124,412
+6866.0%
0.01%
+900.0%
Q3 2017$214,000
-90.5%
1,786
-90.7%
0.00%
-90.0%
Q2 2015$2,242,000
-1.1%
19,201
+102.2%
0.01%0.0%
Q3 2014$2,266,000
+263.1%
9,497
-32.5%
0.01%
+150.0%
Q2 2013$624,00014,0730.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders